Lymphoma is a general term for localized malignancies that develop in the lymphatic or reticuloendothelial system. Its cells are similar to lymphocytes, plasma cells or histiocytes.Hodgkin's disease, discovered by Thomas Hodgkin in 1832, is one type of lymphoma. All other lymphomas are grouped together and are called non-Hodgkin's lymphoma.
Wilmot Cancer Center Expert to Discuss Lymphoma Research
Lymphoma :: Wilmot Cancer Center Expert to Discuss Lymphoma Research
Lymphoma expert Richard I. Fisher, M.D., director of the James P. Wilmot Cancer Center, will discuss the role biology plays in the future treatment of lymphomas as part of a lecture series highlighting biological and biomedical research at the University of Rochester.?The survival rate for lymphoma has risen sharply in recent decades with advances in research and the development of novel therapies. Further advances will come as we are able to understand critical genes that permit lymphoma cells to survive and develop agents specifically to interrupt those pathways,? said Fisher, vice president for Clinical Services for the University of Rochester Medical Center.
Fisher, an internationally known expert in biological research and treatment of lymphoma, has established one of the largest programs in the Northeast at the Wilmot Cancer Center. He has led numerous national and international studies in Hodgkin?s disease and non-Hodgkin?s lymphoma.
(Lymphoma :: Wilmot Cancer Center Expert to Discuss Lymphoma Research published at SpiritIndia on Tuesday, July 3, 2007)
Lymphoma
Search more information on Lymphoma, Lymphoma booksRecently posted related articles on Lymphoma :
- Lymphoma :: Cancer researchers at the University of Pennsylvania discover what makes lymphomas tick
- Skin Cancer :: Rates of cutaneous T-cell lymphoma increase over 30 years
- Lymphoma :: Wilmot Cancer Center Expert to Discuss Lymphoma Research
- Lymphoma :: Risk of lymphoma in rheumatoid arthritis decreased by long-term treatment with steroids
- Lymphoma :: Overall survival and length of disease remission with GSK's BEXXAR
- Lymphoma :: Allos' PDX and Gemcitabine in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
- Lymphoma :: Wilmot Cancer Center Scientist gets $1.5M to Advance Lymphoma Research
- Leukemia :: Childhood leukemia and lymphoma survivors have elevated risk of second cancers
- Hepatitis C :: Hepatitis C increases risk of non-Hodgkin lymphoma
- Leukemia :: Risk of second malignant neoplasms after childhood leukemia and lymphoma
Most related articles:
- Lymphoma :: Wilmot Cancer Center Expert to Discuss Lymphoma Research- Leukemia :: Childhood leukemia and lymphoma survivors have elevated risk of second cancers - 16.3
- Lymphoma :: Wilmot Cancer Center Scientist gets $1.5M to Advance Lymphoma Research - 15.5
- Lymphoma :: Response to Glucocorticoids Predicts Survival with CNS Lymphoma - 14.3
- Lymphoma :: Autoimmune diseases linked with Non-Hodgkin’s Lymphoma - 13.7
- Lymphoma :: BiovaxID - Promising for Follicular Lymphoma - 13.3
- HIV :: AIDS-related cancers decline with introduction of intense antiretroviral therapy - 11.9
- Lymphoma :: Allos' PDX and Gemcitabine in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease - 11.5
- Leukemia :: Risk of second malignant neoplasms after childhood leukemia and lymphoma - 11.5
- Breast Cancer :: Breast cancer survivors to be honored at benefit for Wilmot Research - 11.2
»» Infertility :: Complementary therapy for infertile women may reduce chances of pregnancy
«« Obesity :: Good results for less invasive obesity surgery
The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com